Navigation and service

Cardiovascular Disease

Cardiovascular diseases are the leading cause of death in Germany, causing a total of approximately 40% of all deaths. In addition, they are associated with significant health consequences for the individual and result in high medical costs for society.

Due to their prevalence, coronary heart disease, heart attacks, and stroke have particularly high public health relevance.

The most significant modifiable risk factors for cardiovascular diseases are cardiometabolic illnesses such as hypertension, diabetes mellitus, lipometabolic disorders and obesity, as well as behaviour that is detrimental to health, such as smoking, physical inactivity and an unhealthy diet.

These risk factors can be influenced by health-conscious behaviour and medicinal therapies, and provide great potential for preventing cardiovascular diseases.

Activities at Robert Koch Institute

Within the framework of health monitoring in children and adults, the Robert Koch Institute regularly collects data on significant cardiovascular diseases and their risk factors.

Based on this data, the prevalence and distribution of diseases and risk factors in the population and their development and influencing factors are investigated in epidemiological studies.

Further studies examine such aspects as the interaction of different risk factors, correlation with the living environment and mental health, and healthcare aspects. The search for preventative approaches is of great importance here.


Time Trends in Cardiometabolic Risk Factors in Adults. Results from three nationwide German examination surveys from 1990–2011

Finger JD, Busch MA, Du Y, Heidemann C,; Knopf H, Kuhnert R, Lampert T, Mensink GBM, Neuhauser H, Schaffrath Rosario A, Scheidt-Nave C, Schienkiewitz A, Truthmann J, Kurth BM (2016) Dtsch Arztebl Int 2016; 113(42): 712-9; DOI: 10.3238/arztebl.2016.0712

Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons

Ohlmeier C, Mikolajczyk R, Frick J, Prütz F, Haverkamp W, Garbe E (2015) Clin Res Cardiol. 104(8):688-696 . DOI: 10.1007/s00392-015-0841-4

Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11

Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U (2014) J Hum Hypertens ePub Okt 02. doi: 10.1038/jhh.2014.82. [Epub ahead of print]

Population-wide use of behavioural prevention and counselling programmes for lifestyle-related cardiovascular risk factors in Germany.

Schmitz R, Jordan S, Müters S, Neuhauser H (2012) · Eur. J. Cardiovasc. Prev. Rehabil. · 19(4):849–856 · DOI: 10.1177/1741826711410949

Indicators of Overweight and Cardiovascular Disease Risk Factors among 11- to 17-Year-Old Boys and Girls in Germany.

Kleiser C, Schienkiewitz A, Schaffrath Rosario A, Prinz-Langenohl R, Scheidt-Nave C, Mensink GBM (2011) Obesity Facts, 4 (5), pp. 379-385.

Dietary patterns are associated with cardiometabolic risk factors in a representative study population of German adults

Heidemann C, Scheidt-Nave C, Richter A, Mensink GBM (2011) British Journal of Nutrition 106(8): 1253–1262 doi:10.1017/S0007114511001504

Prevalence of children with blood pressure measurements exceeding adult cutoffs for optimal blood pressure in Germany

Neuhauser HK, Schaffrath Rosario A, Thamm M, Ellert U (2009) Eur. J. Cardiovasc. Prevent. Rehab. 16 (2): 195-200 doi:10.1097/HJR.0b013e3283271e6c

Estimation of the metabolic syndrome prevalence in the general population in Germany.

Neuhauser H, Ellert U (2008) Journal of Public Health 16(3): 221–227

What are the social consequences of stroke for working age adults? A systematic review.

Daniel K, Wolfe CDA, Busch MA, McKevitt C. (2009) Stroke 40: e431–e440 · doi: 10.1161/​STROKEAHA.108.534487

An international comparative study of blood pressure in populations of European vs. African descent

Cooper RS, Wolf-Maier K, Luke A, Adeyemo A, Banegas JR, Forrester T, Giampaoli S, Joffres M, Kastarinen M, Primatesta P, Stegmayr B and Thamm M (2005) BMC Medicine 2005,3:2 doi:10.1186/1741-7015-3-2

Primary prevention of stroke

Neuhauser H (2003) Lancet 362 (9401): 2121–2122. doi:10.1016/S0140-6736(03)15126-4